Novel HIV-1 Microbicides
Novel HIV-1 Microbicides
批准号:
7006803
负责人:
Bharat Ramratnam
金额:
$21.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2007-06-30
关键词:
AIDS education /preventionHIV infectionsMacacaRNA interferenceantiAIDS agentbiotechnologycell surface receptorschemokine receptorconfocal scanning microscopycytokinedrug screening /evaluationenzyme linked immunosorbent assayfluorescent dye /probehost organism interactionhuman immunodeficiency virus 1liposomesmicroorganism disease chemotherapymucosal immunitynonhuman therapy evaluationrectum /anussmall interfering RNAtherapy design /developmentvaginavirus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Heterosexual transmission accounts for the majority of new cases of HIV-1 infection each year. Recent reports from the World Health Organization estimate that a total of 38 million people are now infected with HIV-1 worldwide; 90% of whom live in developing countries. As of 2003, nearly 50% of all infected individuals were women. The increased incidence of HIV-1 infection in women, particularly those of childbearing age, underscores the urgent need for effective preventative and therapeutic options that are safe, affordable and culturally accepted. In the absence of an effective preventative vaccine, topical microbicides may offer a practical alternative to block HIV-1 transmission at the site of entry. We seek funds to determine whether the process of RNA interference (RNAi) can be harnessed to prevent the cervicovaginal transmission of HIV-1 and thereby emerge as a novel microbicidal strategy. This work will be conducted by investigators at Rhode Island Hospital (B. Ramratnam) and Harvard-NEPRC (K. Mansfield). RNAi refers to the sequence-specific degradation of RNA that follows the cellular introduction of homologous, short interfering (si) RNA. We hypothesize that RNAi can be specifically targeted to the vaginal/rectal mucosa and decrease the expression of host factors that mediate HIV-1/SIV mucosal transmission. For these proof-of-principle studies, we will target the CCR5 chemokine receptor in macaques. We will pursue two specific aims over the 24-month period. 1: To characterize the tissue penetrance of liposomal siRNA following direct vaginal/rectal application. 2: To quantify the kinetics and durability of mucosal CCR5 knockdown following single and serial vaginal/rectal applications of siRNA. At the end of the 12-month period, we will have defined the HIV-1 microbicidal potential of siRNA. The full realization of this potential will come from more extended experiments involving vaginal/rectal virus challenge in CCR5 siRNA treated macaques and appropriate controls.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
-
批准号:10356052
-
项目类别:
-
资助金额:$78.64万
-
财政年份:2019
-
负责人:Bharat Ramratnam
-
依托单位:
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
-
批准号:9884730
-
项目类别:
-
资助金额:$80.56万
-
财政年份:2019
-
负责人:Bharat Ramratnam
-
依托单位:
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
-
批准号:10594056
-
项目类别:
-
资助金额:$77.07万
-
财政年份:2019
-
负责人:Bharat Ramratnam
-
依托单位:
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
-
批准号:9752095
-
项目类别:
-
资助金额:$83.06万
-
财政年份:2019
-
负责人:Bharat Ramratnam
-
依托单位:
COBRE Center for Cancer Research Development
-
批准号:8882661
-
项目类别:
-
资助金额:$121.35万
-
财政年份:2015
-
负责人:Bharat Ramratnam
-
依托单位:
Studies in HIV-1 Pathogenesis and Transmission
-
批准号:9033934
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2014
-
负责人:Bharat Ramratnam
-
依托单位:
Studies in HIV-1 Pathogenesis and Transmission
-
批准号:8732335
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2014
-
负责人:Bharat Ramratnam
-
依托单位:
Studies in HIV-1 Pathogenesis and Transmission
-
批准号:9249649
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2014
-
负责人:Bharat Ramratnam
-
依托单位:
MOLECULAR CORE
-
批准号:8360132
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2011
-
负责人:Bharat Ramratnam
-
依托单位:
MOLECULAR CORE
-
批准号:8168495
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2010
-
负责人:Bharat Ramratnam
-
依托单位:
Retrovirology Services
-
批准号:7676175
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2008
-
负责人:Bharat Ramratnam
-
依托单位:
SIRNA MICROBICIDES
-
批准号:7562114
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2007
-
负责人:Bharat Ramratnam
-
依托单位:
P3: RNA INTERFERENCE TO DISSECT STEM CELL POTENTIAL
-
批准号:7610568
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2007
-
负责人:Bharat Ramratnam
-
依托单位:
Retrovirology Services
-
批准号:7278958
-
项目类别:
-
资助金额:$14.02万
-
财政年份:2007
-
负责人:Bharat Ramratnam
-
依托单位:
NOVEL HIV-1 MICROBICIDES
-
批准号:7562068
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2007
-
负责人:Bharat Ramratnam
-
依托单位:
siRNA Microbicides
-
批准号:7132027
-
项目类别:
-
资助金额:$85.0万
-
财政年份:2006
-
负责人:Bharat Ramratnam
-
依托单位:
COBRE: RW HOSP: P3: RNA INTERFERENCE TO DISSECT STEM CELL POTENTIAL
-
批准号:7382034
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2006
-
负责人:Bharat Ramratnam
-
依托单位:
NOVEL HIV-1 MICROBICIDES
-
批准号:7349605
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2006
-
负责人:Bharat Ramratnam
-
依托单位:
siRNA Microbicides
-
批准号:7290435
-
项目类别:
-
资助金额:$71.66万
-
财政年份:2006
-
负责人:Bharat Ramratnam
-
依托单位:
Novel Si RNA microbicides to prevent HIV-1 infectio
-
批准号:7132114
-
项目类别:
-
资助金额:$18.18万
-
财政年份:2006
-
负责人:Bharat Ramratnam
-
依托单位:
海外基金